Skin & hair
GHK-Cu Copper Peptide
Also known as: GHK Cu, Copper peptide, Copper tripeptide-1, GHK copper
What is GHK-Cu?
GHK-Cu is a small, naturally occurring peptide — glycine, histidine and lysine — bound to a copper ion. It was discovered in 1973 in human blood plasma, where its level falls from around 200 ng/mL at age 20 to roughly 80 ng/mL by age 60.
It is the most established peptide in skincare: “copper peptides” have been used in cosmetic serums for decades under the name Copper Tripeptide-1. That is why searches split between topical GHK-Cu (serums and creams) and injectable GHK-Cu (lyophilised research vials).
How GHK-Cu works
GHK has a very high affinity for copper and delivers it into cells, where copper is a cofactor for enzymes such as lysyl oxidase (which crosslinks collagen and elastin) and superoxide dismutase (antioxidant defence). Gene-expression studies suggest GHK shifts the activity of a large number of human genes towards a repair-oriented pattern — increasing collagen, glycosaminoglycan and decorin production while reducing inflammatory and tissue-destroying signals.
Reconstituted GHK-Cu is a distinctive bright blue because of the copper.
What the research shows
- GHK-Cu stimulated collagen synthesis in fibroblast cultures at very low (nanomolar) concentrations.
- In animal wound models it improved healing and blood-vessel growth.
- Small human cosmetic studies reported improved skin density, firmness and fine lines with topical GHK-Cu creams over 12 weeks.
- Hair research: copper peptides have been studied for increasing follicle size, mostly in vitro and small trials.
GHK-Cu side effects
Topical copper peptides are generally well tolerated; irritation, tingling and occasional redness are the most reported effects, and they are commonly not mixed with strong acids or vitamin C in the same application. Injected GHK-Cu has no controlled human safety data; users report stinging at the injection site. People with Wilson's disease or copper-sensitivity should be especially cautious.
UK legal status
GHK-Cu is legal as a cosmetic ingredient (Copper Tripeptide-1) and appears in many UK skincare products. Injectable or high-concentration lyophilised GHK-Cu is not a licensed medicine and is sold for research only.
More detail, including current UK research-vial prices: GHK-Cu UK guide. For the doses used in published studies and the reconstitution maths: GHK-Cu dosing in the literature.
GHK-Cu: frequently asked questions
What is GHK-Cu?
A naturally occurring tripeptide (glycine-histidine-lysine) bound to copper, found in human plasma and widely used in skincare as Copper Tripeptide-1.
What does GHK-Cu do for skin?
It stimulates collagen and elastin production and supports wound repair. Small cosmetic trials reported improved firmness and fewer fine lines with topical use.
Topical vs injectable GHK-Cu?
Topical copper peptides have decades of cosmetic use. Injectable GHK-Cu is a research product with no human trial data.
Why is GHK-Cu blue?
The copper(II) ion gives the reconstituted solution its blue colour. A colourless “GHK-Cu” may not contain copper.
Does GHK-Cu help hair growth?
Lab and small studies suggest copper peptides may increase hair-follicle size, but robust clinical evidence is limited.
References
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19:1987.
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238:343–346.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
Related compounds
GLOW blend
GLOW is a three-peptide blend built on the Wolverine stack with the copper peptide GHK-Cu added.
BlendsKLOW blend
KLOW is the GLOW blend with KPV added — four peptides in one vial.
Tissue repairBPC-157
BPC-157 stands for “Body Protection Compound-157”.
InflammationKPV
KPV is a three-amino-acid peptide (lysine-proline-valine) that forms the very end of alpha-melanocyte-stimulating hormone (α-MSH), a hormone with strong anti-inflammatory effects.